Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Effector Therapeutics
3167
Effector Therapeutics
Technology
Biotechnology
Effector Therapeutics is an early-stage company focused on the discovery anddevelopment of small molecule cancer therapeutics.
Suggest edits
Founded
2012
Raised
$83.6M
Follow us
Also headquartered in San Diego
Qualcomm
Intuit
Dan
GoFundMe
Edge
Industry
Illumina
Bandsintown
TuSimple
San Diego Comic-Con
Companies in the same industry
Physicians Endoscopy
Sprout Pharmaceuticals
Parx Plastics N.V.
Tornado Spectral Systems
Gitte Pedersen
BioSTL
Zinc Ahead
Armune BioScience
Biogen
Rex Animal Health
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$38,600,000
Venture capital (Series C) - 2017
SR One
Novartis Venture Fund
U.S. Venture Partners (USVP)
+9
$45,000,000
Venture capital - 2013
Osage University Partners
SR One
Novartis Venture Fund
+4
Team Size
10+
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
$38,600,000
Venture capital (Series C)
Xconomy
,
vcaonline
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Funding
Health
Science
$40,000,000
Venture capital (Series B)
The San Diego Union-Tribune
Effector Therapeutics raises $40 million
Science
Health
Funding
